FI952059A - Förfarande för framställning av taxanderivat - Google Patents

Förfarande för framställning av taxanderivat Download PDF

Info

Publication number
FI952059A
FI952059A FI952059A FI952059A FI952059A FI 952059 A FI952059 A FI 952059A FI 952059 A FI952059 A FI 952059A FI 952059 A FI952059 A FI 952059A FI 952059 A FI952059 A FI 952059A
Authority
FI
Finland
Prior art keywords
radical
taxane derivatives
phenyl
alkyl
preparation
Prior art date
Application number
FI952059A
Other languages
English (en)
Finnish (fi)
Other versions
FI109798B (sv
FI952059A0 (sv
Inventor
Jean-Noel Denis
Andrew Greene
Alice Kanazawa
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI952059A publication Critical patent/FI952059A/sv
Publication of FI952059A0 publication Critical patent/FI952059A0/sv
Application granted granted Critical
Publication of FI109798B publication Critical patent/FI109798B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952059A 1992-10-30 1995-04-28 Förfarande för framställning av taxanmellanprodukter utgångsämnen för framställning av taxanmellanprodukter och taxanmellanprodukter FI109798B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9213000 1992-10-30
FR9213000A FR2697522B1 (fr) 1992-10-30 1992-10-30 Procédé de préparation de dérivés du taxane.
FR9301058 1993-10-28
PCT/FR1993/001058 WO1994010169A1 (fr) 1992-10-30 1993-10-28 Procede de preparation de derives du taxane

Publications (3)

Publication Number Publication Date
FI952059A true FI952059A (sv) 1995-04-28
FI952059A0 FI952059A0 (sv) 1995-04-28
FI109798B FI109798B (sv) 2002-10-15

Family

ID=9435013

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952059A FI109798B (sv) 1992-10-30 1995-04-28 Förfarande för framställning av taxanmellanprodukter utgångsämnen för framställning av taxanmellanprodukter och taxanmellanprodukter

Country Status (24)

Country Link
US (3) US5686623A (sv)
EP (1) EP0666857B1 (sv)
JP (1) JP3030088B2 (sv)
KR (1) KR100255460B1 (sv)
AT (1) ATE180258T1 (sv)
AU (1) AU679947B2 (sv)
CA (1) CA2148103C (sv)
CZ (1) CZ287805B6 (sv)
DE (1) DE69325031T2 (sv)
DK (1) DK0666857T3 (sv)
ES (1) ES2133418T3 (sv)
FI (1) FI109798B (sv)
FR (1) FR2697522B1 (sv)
GR (1) GR3030268T3 (sv)
HU (1) HUT73780A (sv)
MX (1) MX9306606A (sv)
NO (2) NO304114B1 (sv)
NZ (1) NZ257578A (sv)
PL (1) PL177746B1 (sv)
RU (2) RU2188198C2 (sv)
SK (1) SK281045B6 (sv)
TW (1) TW427988B (sv)
WO (1) WO1994010169A1 (sv)
ZA (1) ZA938012B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
SI0703909T1 (en) * 1993-06-11 2000-08-31 Pharmacia & Upjohn Company Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
IL127599A (en) * 1994-01-28 2004-06-01 Upjohn Co Process for preparing isotaxol analogs
CA2170661A1 (en) 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
EP1099696A3 (en) * 1995-06-06 2001-05-23 Dr. Reddy's Research Foundation Preparation of oxazolidine
WO1998017656A1 (en) * 1996-10-24 1998-04-30 Institute Armand-Frappier A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
US6150537A (en) 1997-12-12 2000-11-21 Emory University Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
EP0982028A1 (en) * 1998-08-20 2000-03-01 Aventis Pharma S.A. New use of taxoid derivatives
TR200100575T2 (tr) * 1998-08-20 2001-07-23 Aventis Pharma S.A. Taksoid türevlerinin yeni kullanım alanları
JP4502338B2 (ja) * 1999-09-17 2010-07-14 株式会社横浜国際バイオ研究所 タキソイド化合物の製造法
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2000261768A1 (en) * 2000-08-08 2002-02-18 Dr. Reddy's Research Foundation An improved process for the preparation of docetaxel
JP2002088935A (ja) 2000-09-14 2002-03-27 Nichiha Corp 外装材の縦目地ジョイナー
WO2006055837A2 (en) 2004-11-19 2006-05-26 Dr. Reddy's Laboratories Ltd. Process for preparing oxazolidine derivatives
CZ298332B6 (cs) * 2005-09-26 2007-08-29 Zentiva, A. S Zpusob prípravy kyseliny (4S,5R)-2,4-difenyloxazolin-4,5-dihydro-5-karboxylové
JP2009521463A (ja) * 2005-12-21 2009-06-04 タペストリー ファーマシューティカルズ インコーポレーテッド タキサン誘導体のための方法およびそれに有用な中間体
WO2008074178A1 (fr) * 2006-11-23 2008-06-26 Shanghai Bailing Pharmaceutical Technology Co., Ltd Nouveau procédé de préparation de paclitaxel semi-synthétique
CN101020672B (zh) * 2006-12-28 2010-08-25 上海百灵医药科技有限公司 多烯紫杉醇的合成方法
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
KR101379694B1 (ko) * 2011-09-30 2014-03-31 주식회사 삼양바이오팜 탁산유도체의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696458B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696464B1 (fr) * 1992-10-05 1994-11-10 Rhone Poulenc Rorer Sa Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2696459B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
SI0703909T1 (en) * 1993-06-11 2000-08-31 Pharmacia & Upjohn Company Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NO951587D0 (no) 1995-04-26
WO1994010169A1 (fr) 1994-05-11
NZ257578A (en) 1996-06-25
KR100255460B1 (ko) 2000-05-01
FR2697522B1 (fr) 1994-11-25
AU679947B2 (en) 1997-07-17
MX9306606A (es) 1994-04-29
PL308638A1 (en) 1995-08-21
DE69325031D1 (de) 1999-06-24
US5686623A (en) 1997-11-11
NO951587L (no) 1995-04-26
CA2148103C (fr) 2002-11-26
NO981813D0 (no) 1998-04-22
ES2133418T3 (es) 1999-09-16
PL177746B1 (pl) 2000-01-31
JPH08502507A (ja) 1996-03-19
HUT73780A (en) 1996-09-30
NO304114B1 (no) 1998-10-26
RU2118958C1 (ru) 1998-09-20
ZA938012B (en) 1994-06-09
DK0666857T3 (da) 1999-11-08
CZ109295A3 (en) 1995-10-18
CA2148103A1 (fr) 1994-05-11
TW427988B (en) 2001-04-01
NO306062B1 (no) 1999-09-13
ATE180258T1 (de) 1999-06-15
HU9501235D0 (en) 1995-06-28
FI109798B (sv) 2002-10-15
RU95111381A (ru) 1996-12-27
RU2188198C2 (ru) 2002-08-27
SK55795A3 (en) 1995-10-11
CZ287805B6 (en) 2001-02-14
US20030013889A1 (en) 2003-01-16
JP3030088B2 (ja) 2000-04-10
FR2697522A1 (fr) 1994-05-06
EP0666857B1 (fr) 1999-05-19
FI952059A0 (sv) 1995-04-28
US6433180B1 (en) 2002-08-13
NO981813L (no) 1995-04-26
DE69325031T2 (de) 1999-10-07
EP0666857A1 (fr) 1995-08-16
SK281045B6 (sk) 2000-11-07
KR950704307A (ko) 1995-11-17
GR3030268T3 (en) 1999-08-31
AU5423794A (en) 1994-05-24

Similar Documents

Publication Publication Date Title
FI952059A (sv) Förfarande för framställning av taxanderivat
MD420C2 (ro) Derivaţi ai acidului acrilic
TW372234B (en) Process for the esterification of baccatin III and 10-deacetylbaccatin III
NZ238207A (en) Enantioselective preparation of phenylisoserine derivatives and baccatin derivatives prepared therefrom
CA2219675A1 (en) Pentacyclic compound
BG101501A (en) Nitro-benzamides useful as anti-arrhytmic agents
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
TW232687B (sv)
MY102457A (en) Isoquinoline derivatives
AU650360B2 (en) Saishin N derivatives, process for preparing same and antiulcer agents containing same
AU637204B2 (en) Aminic derivatives showing fungicidal activity
MX9604465A (es) Procedimiento de preparacion de 7-hidroxi-taxanos.
ES420717A1 (es) Procedimiento para la obtencion de dibenzazecinas.